KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

April 17, 2025 at 21:03 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™” be killed.

The release was issued in error by Aditxt, Inc..

A replacement release will not be issued at this time.

Contacts

Aditxt, Inc.

Corporate Communications

Jeff Ramson, PCG Advisory, Inc.

T: 646-863-6893

contactus@aditxt.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	265.13	-2.15 (-0.80%)
AAPL	305.26	+3.01 (1.00%)
AMD	483.01	+0.08 (0.02%)
BAC	64.09	-0.72 (-1.11%)
GOOG	343.94	+1.57 (0.46%)
META	594.97	+16.12 (2.78%)
MSFT	496.88	+4.45 (0.90%)
NVDA	225.30	+1.21 (0.54%)
ORCL	156.22	+2.94 (1.92%)
TSLA	339.96	+12.45 (3.80%)

Symbol

Price

Change (%)

AMZN

265.13

-2.15 (-0.80%)

AAPL

305.26

+3.01 (1.00%)

AMD

483.01

+0.08 (0.02%)

BAC

64.09

-0.72 (-1.11%)

GOOG

343.94

+1.57 (0.46%)

KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

Contacts

More News

Recent Quotes

Information